University of Maryland School of Medicine Begins Participation in Nationwide N1H1 Vaccine Trials

The University of Maryland School of Medicine will lead a research study on an experimental vaccine to prevent swine flu.

The school’s Center for Vaccine Development will participate in a nationwide network of vaccine evaluation teams funded by the National Institutes of Health.

If the vaccine is found to be safe on young adults and senior citizens, it will then be tested on children.

Officials are hoping to have vaccine ready to be used for the general public by sometime this fall, as health officials worry that there will be an increase of cases of swine flu later this fall, which is traditionally when seasonal fuel outbreaks begin.

If the vaccine is found to be safe on young adults and senior citizens, it will then be tested on children.

Officials are hoping to have vaccine ready to be used for the general public by sometime this fall, as health officials worry that there will be an increase of cases of swine flu later this fall, which is traditionally when seasonal fuel outbreaks begin.